Determining The Value of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Spain By Multi-Criteria Decision Analysis (MCDA)

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.971
https://www.valueinhealthjournal.com/article/S1098-3015(17)31305-0/fulltext
Title : Determining The Value of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Spain By Multi-Criteria Decision Analysis (MCDA)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31305-0&doi=10.1016/j.jval.2017.08.971
First page : A570
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 930
Categories :
Tags :
Regions :
ViH Article Tags :